Molecular Stethoscope
2015
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Seed
LATEST DEAL TYPE
$4.49M
LATEST DEAL AMOUNT
4
INVESTORS
Description
Developer of novel blood based early detection and disease monitoring tests intended to obtain genetic information. The company's disease monitoring tests analyzes circulating cell-free RNA in a blood sample to monitor organ damage, providing early detection of hard-to-detect diseases.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
- 10835 Road to the Cure
- Suite 100
- San Diego, CA 92121
- United States
+1 (858) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Molecular Stethoscope’s full profile, request a free trial.
Molecular Stethoscope Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 04-Oct-2019 | $4.49M | 000.00 | 000.00 | Completed | Startup |
| 2. Seed Round | 05-Jan-2017 | 00.00 | 00.00 | 000.00 | Completed | Startup |
| 1. Seed Round | 21-Oct-2015 | Completed | Startup |
Molecular Stethoscope Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Seed | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Molecular Stethoscope Competitors (20)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novigenix | Corporation | Epalinges, Switzerland | 0 | |||
| 0000000 000000 | Pending Transaction (VC) | Houston, TX | 0000 | 00000 00000 | ||
| 0000000 0000000000 | Venture Capital-Backed | New York, NY | 0 | 00000 | 0000000000 | 00000 |
| 00000000000 000000 | Venture Capital-Backed | Birmingham, AL | 00 | 00.000 | 0000000000 0 | 00.000 |
| 000000 | Venture Capital-Backed | Richmond Hill, Canada | 00 | 000.00 | 00000000000 | 000.00 |
Molecular Stethoscope Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Arab Angel | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Index Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Pfizer | Corporation | Minority | 000 0000 | 000000 0 | ||
| Data Collective | Venture Capital | Minority | 000 0000 | 000000 0 |
Molecular Stethoscope Executive Team (7)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Guillermo Elias | Chief Executive Officer | ||
| Stephen Quake Ph.D | Co-Founder & Board Member | ||
| Eric Topol MD | Co-Founder & Board Member |
4 Former Executives
You’re viewing 3 of 7 executives. Get the full list »Molecular Stethoscope Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Arda Minocherhomjee Ph.D | Self | Board Member | 000 0000 | |
| Eric Topol MD | Self | Co-Founder & Board Member | 000 0000 | |
| Stephen Quake Ph.D | Molecular Stethoscope | Co-Founder & Board Member | 000 0000 | |
| Tina Nova Ph.D | Molecular Stethoscope | Board Member | 000 0000 |